NCT00571805View on ClinicalTrials.gov

Study of Varencline Effects on Cigarette Smoking Reward and Craving During a Model of Brief Quit Attempt

PHASE1/PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

September 30, 2007

Conditions
Nicotine Dependence
Interventions
DRUG

varencline

2.0 mg/day varencline (1.0 mg BID)

DRUG

placebo

matching placebo

Trial Locations (1)

10010

VA New York Harbor Healthcare System, MHAD clinic, New York

Sponsors

Collaborators (1)

Pfizer
All Listed Sponsors
collaborator

Pfizer

INDUSTRY

lead

NYU Langone Health

OTHER